Carmine Therapeutics

Carmine was founded by Esco Ventures X, Professors Harvey Lodish (Whitehead, MIT), Minh Le and Jiahai Shi. Professor Lodish, who was a founding member of several successful biotech companies that include GenzymeGenzyme and Millennium Pharmaceuticals, is also Chair of the Scientific Advisory Board of Carmine.

Carmine was founded by Esco Ventures X, Professors Harvey Lodish (Whitehead, MIT), Minh Le and Jiahai Shi. Professor Lodish, who was a founding member of several successful biotech companies that include Genzyme and Millennium PharmaceuticalsMillennium Pharmaceuticals, is also Chair of the Scientific Advisory Board of Carmine.

Carmine Therapeutics is a company that is developing novel types of gene therapies utilizing extracellular vesicles produced in the laboratory. It is pioneering a new class of non-viral gene therapeutics which is based on red blood cell extracellular vesicles, combined with proprietary payloads.

In June 2020, Carmine inked a research alliance with Takeda Pharmaceuticals worth up to $900 million to develop non-viral gene therapies for 2 targets.

Carmine was founded by Esco Ventures X, Professors Harvey Lodish (Whitehead, MIT), Minh Le and Jiahai Shi. Professor Lodish, who was a founding member of several successful biotech companies that include Genzyme and Millennium Pharmaceuticals, is also Chair of the Scientific Advisory Board of Carmine.